ABMGG Clinical Biochemical Genetics study guide
ABMGG Clinical Biochemical Genetics · Work through your exam, one topic at a time.
Clinical Biochemical Genetics is one of the specialty certifications offered by the American Board of Medical Genetics and Genomics (ABMGG), a board whose stated mission is "to serve the public and medical profession by establishing professional certification standards and promoting lifelong learning as well as excellence in medical genetics and genomics." The credential is intended for physicians and laboratory geneticists who diagnose and manage inborn errors of metabolism, integrating biochemical testing with molecular and clinical data. Candidates typically reach the examination after completing an accredited training program and an approved application; ABMGG publishes content outlines and blueprints, exam requirements, testing process details, scoring information, and pass rates on its Initial Certification pages, and those documents - not third-party summaries - are the authoritative statement of what the exam covers. The ABMGG Clinical Biochemical Genetics study guide has 5 sections and about 1,607 words.
01Clinical and Laboratory Diagnosis of Inborn Errors of Metabolism
Inborn errors of metabolism (IEMs) present as symptom clusters, not as named diseases: encephalopathy with hyperammonemia, hypoglycemia without ketosis, metabolic acidosis with an elevated anion gap, hyperammonemia with respiratory alkalosis, cardiomyopathy, hepatosplenomegaly, or a dysmorphic/neurodegenerative course. The candidate must be able to move from a clinical pattern to a first-tier biochemical panel (ammonia, blood gas, lactate, glucose, ketones, plasma amino acids, acylcarnitine profile, urine organic acids, homocysteine, and urine glycosaminoglycans/organic acids as indicated) before ordering expensive molecular testing.
388 words, about 2 min02Biochemical and Molecular Testing Methodologies, Including Newborn Screening
Candidates must distinguish screening , diagnostic biochemical , and confirmatory molecular testing, and know the performance characteristics of each. Newborn screening (NBS) uses dried blood spots analyzed by tandem mass spectrometry (MS/MS) for amino acids and acylcarnitines, immunoassay or MS/MS for endocrine and other analytes, and molecular methods for selected conditions (e.g., cystic fibrosis, spinal muscular atrophy, severe combined immunodeficiency).
359 words, about 2 min03Pathophysiology and Natural History of Metabolic Disorders
The candidate should be able to explain disease at the level of the pathway: intoxication disorders (urea cycle defects, organic acidemias, aminoacidopathies) accumulate toxic intermediates and often present after a symptom-free interval; energy deficiency disorders (fatty acid oxidation defects, mitochondrial disorders, glycogen storage diseases) present with hypoketotic hypoglycemia, lactic acidosis, or exercise intolerance; storage disorders (lysosomal and peroxisomal diseases) accumulate substrate and present with progressive organomegaly, neurodegeneration, or skeletal disease; and transport or signaling defects present with specific organ phenotypes. Understand that many IEMs have a spectrum from severe neonatal presentation to attenuated adult-onset disease, and that the same enzyme deficiency can produce different phenotypes depending on residual activity, tissue expression, and environmental triggers (fasting, illness, protein load).
286 words, about 1 min04Treatment and Management of Metabolic Disorders
Management follows directly from pathophysiology: reduce substrate load (dietary restriction of the offending amino acid or protein, avoidance of fasting), increase clearance (hydration, carnitine supplementation, dialysis for severe hyperammonemia), bypass the block (cofactor supplementation such as biotin, thiamine, pyridoxine, riboflavin, or carnitine; alternate pathway drugs such as sodium benzoate/phenylbutyrate for urea cycle defects; sapropterin for BH4-responsive phenylketonuria), and support affected organs (enzyme replacement for selected lysosomal diseases, substrate reduction, hematopoietic stem cell transplantation for selected disorders). Acute decompensation requires a sick-day protocol: stop protein intake temporarily, provide high-energy carbohydrate to suppress catabolism, correct acidosis and electrolytes, treat infection, and escalate to dialysis for refractory hyperammonemia.
284 words, about 1 min05Genetic Counseling, Communication, and Laboratory Stewardship/Quality
Candidates must integrate inheritance patterns (autosomal recessive, X-linked, mitochondrial, imprinting) with test results and family goals. Key tasks: explain the diagnosis in plain language, describe recurrence risk, discuss reproductive options (carrier testing, prenatal diagnosis, preimplantation testing), and address uncertainty when results are variants of uncertain significance or when biochemical and molecular results conflict.
290 words, about 1 min